You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 10, OCTOBER 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (95)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Prognostic Factors in Lupus Nephritis

The Importance of Hypertension and Smoking

Michael M. Ward, MD, MPH; Stephanie Studenski, MD, MPH

Arch Intern Med. 1992;152(10):2082-2088.


Abstract

Background.—
Many previous studies of the influence of sociodemographic and clinical factors on the development of renal failure in patients with lupus nephritis have been based on selected subgroups of patients and have yielded conflicting results. We sought to determine the prognostic importance of patient demographic characteristics (age, gender, race, and socioeconomic status), smoking status, and hypertension in the development of end-stage renal disease (ESRD) among patients with lupus nephritis.

Methods.—
This retrospective cohort study followed an inception cohort of 160 adults with lupus nephritis. The outcome measure was the development of ESRD, defined as the institution of maintenance dialysis or measurement of a creatinine clearance of 10 mL/min or less. Life-table analysis was used to determine differences between patient subgroups in the time to development of ESRD.

Results.—
End-stage renal disease developed in 41 (26%) of 160 patients followed up for a median of 6.4 years. Hypertension and smoking status at the onset of nephritis were strongly associated with differences in the time to development of ESRD. The median time to ESRD among patients with moderate to severe hypertension (diastolic blood pressure, ≥105 mm Hg) was 7 months, among patients with mild hypertension (diastolic blood pressure, 90 to 104 mm Hg) it was 146 months, and among normotensive patients it was greater than 273 months.The median time to ESRD among smokers was 145 months and among nonsmokers it was greater than 273 months. These effects persisted in multivariable analyses adjusting for differences among patients in age, gender, socioeconomic status, renal histology, and immunosuppressive treatment. The independent effects of hypertension and smoking resulted in shorter times to renal failure among patients who were both hypertensive and smoking, compared with nonsmoking hypertensive patients. The development of ESRD did not differ among patient demographic subgroups.

Conclusion.—
Patient demographic characteristics had no detectable impact on the rate of progression to ESRD in this cohort. Hypertension and smoking appear to be important, potentially modifiable, factors influencing the prognosis of patients with lupus nephritis.

(Arch Intern Med. 1992;152:2082-2088)



Author Affiliations

From the Veterans Affairs/Robert Wood Johnson Clinical Scholars Program, and Division of Immunology and Rheumatology, Department of Medicine, Stanford (Calif) University School of Medicine (Dr Ward), and Divisions of Geriatrics and Rheumatology and Immunology, Department of Medicine, Duke University Medical Center, Durham, NC (Dr Studenski).


Footnotes

Accepted for publication May 14, 1992.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Factors Associated with Arterial Vascular Events in PROFILE: A Multiethnic Lupus Cohort
Bertoli et al.
Lupus 2009;18:958-965.
ABSTRACT  

Young Investigator Award Lecture of the APS Water and Electrolyte Homeostasis Section, 2008: The pathophysiology of hypertension in systemic lupus erythematosus
Ryan
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009;296:R1258-R1267.
ABSTRACT | FULL TEXT  

Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients Absence of Evidence or Evidence of Absence?
Orth and Hallan
CJASN 2008;3:226-236.
ABSTRACT | FULL TEXT  

Cocaine Use and Hypertensive Renal Changes in HIV-Infected Individuals
Fine et al.
CJASN 2007;2:1125-1130.
ABSTRACT | FULL TEXT  

Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort
Burling et al.
Lupus 2007;16:830-837.
ABSTRACT  

Cigarette smoking and chronic allograft nephropathy
Zitt et al.
Nephrol Dial Transplant 2007;22:3034-3039.
ABSTRACT | FULL TEXT  

How does early chronic kidney disease progress?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease
Metcalfe
Nephrol Dial Transplant 2007;22:ix26-ix30.
FULL TEXT  

Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage
Bertoli et al.
Lupus 2007;16:410-417.
ABSTRACT  

Nicotine: the link between cigarette smoking and the progression of renal injury?
Jaimes et al.
Am. J. Physiol. Heart Circ. Physiol. 2007;292:H76-H82.
ABSTRACT | FULL TEXT  

Smoking Induces Glomerulosclerosis in Aging Estrogen-Deficient Mice through Cross-Talk between TGF-beta1 and IGF-I Signaling Pathways
Elliot et al.
J. Am. Soc. Nephrol. 2006;17:3315-3324.
ABSTRACT | FULL TEXT  

Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
Costenbader and Karlson
Lupus 2006;15:737-745.
ABSTRACT  

Cigarette smoking and the risk of systemic lupus erythematosus and rheumatoid arthritis.
Majka and Holers
Ann Rheum Dis 2006;65:561-563.
FULL TEXT  

Association between Smoking and Chronic Renal Failure in a Nationwide Population-Based Case-Control Study
Ejerblad et al.
J. Am. Soc. Nephrol. 2004;15:2178-2185.
ABSTRACT | FULL TEXT  

Risk Factors for Chronic Kidney Disease: A Prospective Study of 23,534 Men and Women in Washington County, Maryland
Haroun et al.
J. Am. Soc. Nephrol. 2003;14:2934-2941.
ABSTRACT | FULL TEXT  

Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity
Barr et al.
Nephrol Dial Transplant 2003;18:2039-2046.
ABSTRACT | FULL TEXT  

Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment
Fiehn et al.
Ann Rheum Dis 2003;62:435-439.
ABSTRACT | FULL TEXT  

Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes
Poulsen
Journal of Renin-Angiotensin-Aldosterone System 2002;3:222-242.
ABSTRACT  

Smoking and the Kidney
Orth
J. Am. Soc. Nephrol. 2002;13:1663-1672.
FULL TEXT  

Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis
Bastian et al.
Lupus 2002;11:152-160.
ABSTRACT  

Changes in the Incidence of End-stage Renal Disease Due to Lupus Nephritis, 1982-1995
Ward
Arch Intern Med 2000;160:3136-3140.
ABSTRACT | FULL TEXT  

Smoking and the kidney
Orth et al.
Nephrol Dial Transplant 2000;15:1509-1511.
FULL TEXT  

Renal effects of smoking: potential mechanisms and perspectives
Halimi and Mimran
Nephrol Dial Transplant 2000;15:938-940.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.